BioInsights - Leveraging cutting edge tools to convert I-O data into knowledge - spotlight

IMMUNO-ONCOLOGY INSIGHTS

Leveraging cutting edge tools to convert I-O data into knowledge

Guest Editor:

Jacques Moisan, Translational Innovation Platform - Immuno-Oncology Scientific Site Head (USA) at EMD Serono, Inc

September 2021

Download full spotlight

Yes, IMMUcan! Unraveling the human tumor microenvironment

H Hong,

R Liechti,

M Morfouace

14 October 2021

Commentary

Read more
Expert Roundtable: leveraging cutting edge tools to convert I-O data into knowledge

A Sood,

S Prabhakaran,

G Goldmacher et al.

12 October 2021

Expert Roundtable Video

Watch now
Expert Roundtable: leveraging cutting edge tools to convert I-O data into knowledge

A Sood,

S Prabhakaran,

G Goldmacher et al.

12 October 2021

Expert Roundtable

Read more
Cell-based therapies for cancer treatment: leveraging advanced flow cytometry for greater clinical insight

11 October 2021

Innovator Insight

Read more
Cancer in 4D: the importance of spatial and temporal heterogeneity through breast cancer molecular cartography

C Martinez

11 October 2021

Commentary

Read more
The use of artificial intelligence in immuno-oncology drug discovery: are we closing the gap?

C Boutton,

M Wendt

8 October 2021

Expert Insight

Read more
Overcoming purification challenges in antibody therapeutics manufacturing with subdomain-specific affinity solutions

L Sierkstra

7 September 2021

Innovator Insight

Read more
Reaching for the stars: combining astronomy and pathology to map cancer biomarkers

J Taube,

A Szalay

7 September 2021

Interview

Read more
Gain deeper insights into the mechanisms of immune cell killing of tumor cells: accelerate your time to answer with integrated software analysis

Dr Colby Souders, Chief Scientific Officer, Abveris

Tim Dale, PhD, Head of BioAnalytics Applications, Sartorius

Nicola Bevan, Manager of Cell Imaging Applications, Sartorius

Jeffrey Skolnik, M.D., Senior Vice President, Clinical Development, Inovio

6 October 2021

Webinar

Watch now
Next steps in unlocking the power of computational biology for I-O target identification and validation

N Wang

18 August 2021

Interview

Read more
The therapeutic gene editing solution – cell therapy for solid tumors

Barbra Sasu, PhD, Chief Scientific Officer, Allogene Therapeutics

Pallavur Sivakumar, PhD, Scientific Vice President and Head of Discovery, Immuno-Oncology and Cell Therapy Thematic Research Center, Bristol Myers Squibb

James Trager, PhD, Chief Scientific Officer, Nkarta Therapeutics

Jennifer Harbottle, PhD, Senior Scientist, R&D, Cell and Gene Therapy, Horizon Discovery

30 September 2021

Webinar

Watch now